Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
Karen Sliwa(University of Cape Town), John J.V. McMurray(University of Glasgow), Sabine Pankuweit(Universitätsklinikum Gießen und Marburg), Eckhart Buchmann(University of the Witwatersrand), Luigi Tavazzi(Maria Cecilia Hospital), Hugh Watkins(John Radcliffe Hospital), Uri Elkayam(Icahn School of Medicine at Mount Sinai), Zoltán Papp(University of Debrecen), Vera Regitz‐Zagrosek(Charité - Universitätsmedizin Berlin), Maria Schaufelberger(Apple (Israel)), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), Dirk J. van Veldhuisen(University Medical Center Groningen), Petar Seferović, Frédéric Mouquet(Centre Hospitalier Universitaire de Lille), Mark C. Petrie(British Heart Foundation), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 1,082
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
|European Heart Journal|2015|3.9k